Get the Stockscreener App
67.18
1.11%
0.74
Lantheus Holdings Inc stock is traded at $67.18, with a volume of 677.28K.
It is up +1.11% in the last 24 hours and down -1.22% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$66.44
Open:
$66.59
24h Volume:
677.28K
Relative Volume:
0.63
Market Cap:
$4.45B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
11.18
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
+2.69%
1M Performance:
-1.22%
6M Performance:
-7.13%
1Y Performance:
-29.57%
1-Day Range:
$65.97
$67.92
1-Week Range:
$63.37
$67.92
52-Week Range:
$47.25
$111.29
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
67.18 | 4.41B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
124.40 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.94 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.33 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.66 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
472.06 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Upgrade | Truist | Hold → Buy |
| Oct-08-25 | Downgrade | Goldman | Buy → Neutral |
| Aug-12-25 | Downgrade | Truist | Buy → Hold |
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
Portfolio Shifts: Whats the MACD signal for Lantheus Holdings IncMarket Volume Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
First National Advisers LLC Cuts Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings, Inc. (NASDAQ:LNTH) Sees Large Drop in Short Interest - MarketBeat
Reinhart Partners LLC. Sells 55,903 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Long-Term Investors in Lantheus Holdings, Inc. (NASDAQ: LNTH) - openPR.com
LNTH Stock Price, Forecast & Analysis | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - Chartmill
Lantheus: Management And Competition Raise Real Concern (Rating Downgrade) (NASDAQ:LNTH) - Seeking Alpha
Block Trades: Does APLS outperform in volatile marketsExit Point & Fast Entry High Yield Tips - baoquankhu1.vn
Risks Report: Will Lantheus Holdings Inc stock deliver long term returnsWeekly Profit Recap & Free Technical Pattern Based Buy Signals - Bộ Nội Vụ
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Polaris Capital Management LLC Invests $32.69 Million in Lantheus Holdings, Inc. $LNTH - MarketBeat
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Iovance Biotherapeutics, Inc. (IOVA), Nutex Health, Inc. (NUTX), Lantheus Holdings, Inc. (LNTH), and Molina Healthcare, Inc. (MOH) - GlobeNewswire
Technical Reactions to LNTH Trends in Macro Strategies - Stock Traders Daily
Is Lantheus Holdings Inc. stock recession proofSeasonal Picks & lightweight options for faster days - Улправда
Buyback Watch: How buybacks impact Lantheus Holdings Inc. stock valueChart Signals & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
How Lantheus Holdings Inc. stock benefits from global expansionIPO Watch & Weekly Market Pulse Updates - ulpravda.ru
How buybacks impact Lantheus Holdings Inc. stock valueWeekly Market Summary & Low Risk Profit Maximizing Plans - ulpravda.ru
Is Lantheus Holdings Inc. stock a safe haven asset2025 Risk Factors & Real-Time Volume Spike Alerts - ulpravda.ru
Is Lantheus Holdings Inc. stock a buy on dipsPortfolio Gains Summary & Low Risk High Win Rate Stock Picks - ulpravda.ru
LNTH: Lantheus Closes SPECT Sale - Zacks Small Cap Research
Lantheus Holdings Inc (NASDAQ:LNTH) Presents a Compelling Value Case with Strong Fundamentals - Chartmill
LNTHADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and Progenics - ADVFN
Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027 - ADVFN
Stanley Laman Group Ltd. Acquires 22,229 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
SHINE Completes Acquisition of Lantheus SPECT Business, Names Michael Rossi SHINE SPECT CEO - marketscreener.com
Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China's NMPA - ADVFN
Revisiting Lantheus (LNTH) Valuation After Its Recent Three-Month Share Price Rebound - Yahoo Finance
Lantheus Closes SPECT Business Sale to SHINE Technologies - citybiz
Lantheus closes SPECT business sale to SHINE Technologies - Yahoo Finance
Lantheus completes sale of SPECT business to SHINE Technologies By Investing.com - Investing.com Nigeria
Lantheus Holdings Stock (LNTH) Opinions on SPECT Business Sale - Quiver Quantitative
SHINE Technologies LLC completed the acquisition of SPECT business of Lantheus Holdings, Inc.. - marketscreener.com
Lantheus completes sale of SPECT business to SHINE Technologies - Investing.com India
Lantheus (LNTH) Concludes Sale of SPECT Business to SHINE Techno - GuruFocus
LNTH FinancialsIncome Statement - Quiver Quantitative
Lantheus Holdings, Inc. Completes Sale of SPECT Business to SHINE Technologies, LLC - Quiver Quantitative
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies - The Manila Times
Radiopharmaceutical company sells SPECT diagnostics unit to SHINE - Stock Titan
Trading the Move, Not the Narrative: (LNTH) Edition - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2026-01-01 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Investors to Learn More About the Investigation | NDAQ:LNTH | Press Release - Stockhouse
The Truth About Lantheus Holdings Inc (LANT): Silent Biotech Stock That Might Be Way Too Cheap - AD HOC NEWS
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Osaic Holdings Inc. Boosts Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect - ACCESS Newswire
2025-12-28 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect | NDAQ:LNTH | Press Release - Stockhouse
Voya Investment Management LLC Has $2.41 Million Stock Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Pacer Advisors Inc. Boosts Stock Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings, Inc. $LNTH Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):